alendronate and isosorbide-5-mononitrate

alendronate has been researched along with isosorbide-5-mononitrate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Nabhan, AF; Rabie, NH	1
Dahiya, K; Duhan, N; Nanda, S; Sirohiwal, D; Siwach, RC; Yadav, K	1

Trials

2 trial(s) available for alendronate and isosorbide-5-mononitrate

Article	Year
Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 103, Issue:3 Topics: Absorptiometry, Photon; Alendronate; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Female; Hospitals, University; Humans; Isosorbide Dinitrate; Middle Aged; Nitric Oxide Donors; Osteoporosis, Postmenopausal; Treatment Outcome	2008
Comparative evaluation of isosorbide mononitrate and alendronate in management of postmenopausal osteoporosis. Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:4 Topics: Absorptiometry, Photon; Aged; Alendronate; Bone Density Conservation Agents; Bone Remodeling; Female; Humans; Isosorbide Dinitrate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies	2012

Article

Year

Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 103, Issue:3

Topics: Absorptiometry, Photon; Alendronate; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Female; Hospitals, University; Humans; Isosorbide Dinitrate; Middle Aged; Nitric Oxide Donors; Osteoporosis, Postmenopausal; Treatment Outcome

2008

Comparative evaluation of isosorbide mononitrate and alendronate in management of postmenopausal osteoporosis.

Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:4

Topics: Absorptiometry, Photon; Aged; Alendronate; Bone Density Conservation Agents; Bone Remodeling; Female; Humans; Isosorbide Dinitrate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies

2012

Other Studies

1 other study(ies) available for alendronate and isosorbide-5-mononitrate

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004